拉米夫定治疗失代偿肝炎后肝硬化的临床研究

王大力1;周建方1;刘玲2

引用本文:	王大力1;周建方1;刘玲2.拉米夫定治疗失代偿肝炎后肝硬化的临床研究[J].中国现代应用药学,2006,(7):716-718.
	WANG Dali~(1),ZHOU Jian-fang~(1),LIU Ling~(2).Clinical study of lamivudine treatment on patients with dencompensated cirrhosis post hepatitis[J].Chin J Mod Appl Pharm(中国现代应用药学),2006,(7):716-718.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 1805次下载 1246次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
拉米夫定治疗失代偿肝炎后肝硬化的临床研究
王大力1;周建方1;刘玲2

作者	单位
王大力1;周建方1;刘玲2

摘要:

关键词: 拉米夫定慢性乙型肝炎失代偿肝硬化

DOI：

分类号:

基金项目:

Clinical study of lamivudine treatment on patients with dencompensated cirrhosis post hepatitis

WANG Dali~(1),ZHOU Jian-fang~(1),LIU Ling~(2)

Abstract:

OBJECTIVE To observe the efficiency and safety of long-term lamivudine used in dencompensated cirrhosis following chronic hepatitis B.METHODS 31 patients with dencompensated cirrhosis were divided randomly into two grops:sixteen patients with dencompensat

Key words: lamivudine chronic hepatitis B dencompensated cirrhosis